Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Botox approved to treat migraines

  • Comment

Botox injections have been approved for use in treating migraine sufferers by the US Food and Drug Administration (FDA).

The drug, which is more commonly used in cosmetic procedures to smooth wrinkles, works by blocking the connections between nerves and muscle, temporarily paralysing tissue.

Individuals who suffer from migraine attacks once every other day can now undergo Botox treatment, which is a purified form of botulinum and one of the most toxic substances in the world.

The FDA approved the new use after evaluating findings from two company studies of more than 1,300 patients who received either a Botox injection or a dummy injection.

Patients who received Botox reported slightly fewer “headache days” than patients given the placebo treatment. In one study, Botox patients reported approximately two fewer headache days than patients who did not receive the drug.

The ruling comes after Botox was approved to treat spasms in the elbows, wrists and fingers earlier in the year. It is also used to treat other movement disorders like cerebral palsy.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.